# The manufacturer is pfizer
# Varenicline or Chantix is a smoking cessation medicine.
# Chantix was approved by FDA on May 11, 2006
# Varenicline is designed to reduce nicotine craving and withdrawal effects
# It blocks the receptors in the brain that are linked to an addiction to nicotine.
# The active ingredient in Chantix is Varenicline Tartrate
# A 12 week study shows success rate of 44% in smoking cessation
# 1 year study shows 22% abstinance
# Chantix 1 MG twice daily dose is most effective compared to any other smoke cessation medicine.
# Chantix medication is not recommended in combination with any other smoking cessation medicines. |
# Manufacturer is GlaxoSmithKline.
# Bupropion or Zyban is an aid to smoking cessation treatment.
# Zyban was approved by FDA on May 14, 1997
# It was designed mainly to treat a condition called major depressive disorder.
# The mechanism which enhances the ability of patients to abstain from smoking is unknown.
# The active ingradient in Zyban is Bupropion Hydrochloride
# A 12 week study shows Success rate 29.5 % in smoking cessation
# 1 year study shows 16% abstinance
# Zyban 150 MG twice daily dose works better than placebo but less effective compared to Chantix.
# Combination treatment of ZYBAN and NTS may be prescribed for smoking cessation. |
